The DOI matches its Crossref record; 18 of the 18 references it cites were found in a registry or an index.
TRANSFERRIN AND TRANSFERRIN RECEPTORS IN CARCINOMA OF THE BREAST
Abstract
Breast tissues from 59 patients were immunohistologically studied for transferrin and transferrin receptors. None of the 8 normal breasts or 22 benign mastopathies, and only 1 of 7 fibroadenomas were reactive for transferrin, but 16 (72.7%) of 22 carcinomas were positive and parallel sections showed histopathologically that the rective areas were confined to tumour-cell membranes. That breast-tumour transferrin is probably receptor-bound in vivo was indicatd by its complete chemical removal in vitro and return to the same cells following reincubation with dilute solutions of transferrin. Similar bindig is found on certain normal or transformed cells and at the maternofetal interface of human placentae. It is suggested that this oncofetal receptor preferentially binds apotransferrin and may offer a novel approach to more specific therapy of certain breast cancers.
Overview
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“Upregulation of this highly conserved iron acquisition pathway is found in a variety of cancers, including breast and colon [90,91,92,93].”
From Iron as a central player and promising target in cancer progression (2019) · cites this paper as [90]
Citations
Cites
Host antigens in schistosomiasis
Smithers, S. R., Terry, R. J., & HOCKLEY, D. J. (1969) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1969.0007 · Cited by 281
Glutaradehyde-activated aminohexyl-derivative of sepharose 4B as a new versatile immunoabsorbent
Cambiaso, C. L., Goffinet, A., Vaerman, J. P., & Heremans, J. F. (1975) · Immunochemistry · doi:10.1016/0019-2791(75)90175-5 · Cited by 217
Hakomori, S., Wang, S.-M., & Young, W. W. (1977) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.74.7.3023 · Cited by 181
Faulk, W. P., Temple, A., Lovins, R. E., & SMITH, N. C. (1978) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.75.4.1947 · Cited by 178
Wada, H., Hass, P. E., & Sussman, H. H. (1979) · Journal of Biological Chemistry · doi:10.1016/s0021-9258(19)86360-3 · Cited by 174
Faulk, W. P., & Johnson, P. (1977) · PubMed · Cited by 134
Transferrin binding by human lymphoblastoid cell lines and other transformed cells
Galbraith, G. M. P., Galbraith, R. M., & Faulk, W. P. (1980) · Cellular Immunology · doi:10.1016/0008-8749(80)90072-6 · Cited by 100
Recent Developments in Immunofluorescence
Faulk, W. P., & Hijmans, W. (2015) · Chemical immunology/Fortschritte der Allergielehre/Progress in allergy/Chemical immunology and allergy · doi:10.1159/000393067 · Cited by 86
Faulk, W. P., & Galbraith, G. M. P. (1979) · Proceedings of the Royal Society B Biological Sciences · doi:10.1098/rspb.1979.0014 · Cited by 81
Johnson, P., & Faulk, W. P. (1978) · PubMed · Cited by 69
Research works printed but not linked: 3
- Faulk, 1980, Immunological studies of human placentæ: Basic and practical implications, Rec Adv Clin Immunol, 2, 1
- Galbraith, 1979, Removal of unwanted staining in fluroescence microscopy, J Lab Clin Immunol, 1, 163
- Faulk, 1976, Non-specific factors of resittance in human plancentæ, Protides Biol Fluids, 24, 139
Cited by
Sorted by citations
Items 101–200 of 278
Magro, G. G., Cataldo, I., Amico, P., Torrisi, A. A. M., Vecchio, G. M., Parenti, R., Asioli, S., Recupero, D., D’Agata, V., Mucignat, M. T., et al. (2011) · Thyroid · doi:10.1089/thy.2010.0173 · Cited by 47
Morré, D. J., Kim, C., Paulik, M. A., Morré, D. M., & Faulk, W. P. (1997) · Journal of Bioenergetics and Biomembranes · doi:10.1023/a:1022414228013 · Cited by 46
Epidermal growth factor receptors on ependymomas and other brain tumors
Hall, W. A., Merrill, M. J., Walbridge, S., & Youle, R. J. (1990) · Journal of neurosurgery · doi:10.3171/jns.1990.72.4.0641 · Cited by 46
Lloyd, J. M., O'Dowd, T., Driver, M., & Tee, D. E. H. (1984) · Journal of Clinical Pathology · doi:10.1136/jcp.37.2.131 · Cited by 46
Weinberg, E. D. (1982) · Nutrition and Cancer · doi:10.1080/01635588209513761 · Cited by 46
Uptake and release of transferrin and iron by mitogen‐stimulated human lymphocytes
Bomford, A. B., Young, S. P., Nouri‐Aria, K. T., & Williams, R. L. (1983) · British Journal of Haematology · doi:10.1111/j.1365-2141.1983.tb01227.x · Cited by 46
Weinberg, E. D. (1992) · Biological Trace Element Research · doi:10.1007/bf02785242 · Cited by 45
Hemin regulates the expression of transferrin receptors in human hematopoietic cell lines
Pelicci, P. G., Tabilio, A., THOMOPOULOS, P., Titeux, M., Vainchenker, W., Rochant, H., & Testa, U. (1982) · FEBS Letters · doi:10.1016/0014-5793(82)80198-1 · Cited by 45
Vogel, W., Bomford, A. B., Young, S., & Williams, R. L. (1987) · Blood · doi:10.1182/blood.v69.1.264.264 · Cited by 45
Killing of human tumor cells in culture with adriamycin conjugates of human transferrin
Yeh, C. G., & Faulk, W. P. (1984) · Clinical Immunology and Immunopathology · doi:10.1016/0090-1229(84)90037-0 · Cited by 44
Cytotoxic effects of a doxorubicin-transferrin conjugate in multidrug-resistant KB cells
Fritzer, M., Szekeres, T., Szüts, V., Jarayam, H. N., & Goldenberg, H. (1996) · Biochemical Pharmacology · doi:10.1016/0006-2952(95)02225-2 · Cited by 43
Targeting receptors, transporters and site of absorption to improve oral drug delivery.
Hamman, J. H., Demana, P. H., & Olivier, E. I. (2007) · Europe PMC (PubMed Central) · Cited by 42
Soluble and cell-associated transferrin receptor in lung cancer
Dowlati, A., Loo, M., Bury, T., Fillet, G., & Beguin, Y. P. (1997) · British Journal of Cancer · doi:10.1038/bjc.1997.307 · Cited by 42
Lesley, J., Domingo, D. L., Schulte, R. J., & Trowbridge, I. S. (1984) · Experimental Cell Research · doi:10.1016/0014-4827(84)90583-4 · Cited by 42
Iron Chelators with Topoisomerase-Inhibitory Activity and Their Anticancer Applications
Rao, V. A. (2013) · Antioxidants & Redox Signaling · doi:10.1089/ars.2012.4877 · Cited by 37
Wrba, F., Ritzinger, E., Reiner, A., & Holzner, J. H. (1986) · Archiv für Pathologische Anatomie und Physiologie und für Klinische Medicin · doi:10.1007/bf00710908 · Cited by 41
Transferrin receptor in oral tumors
Miyamoto, T., Tanaka, N., Eishi, Y., & Amagasa, T. (1994) · International Journal of Oral and Maxillofacial Surgery · doi:10.1016/s0901-5027(05)80039-6 · Cited by 41
Cytotoxicity of a transferrin‐adriamycin conjugate to anthracycline‐resistant cells
Fritzer, M., Barabás, K., Szüts, V., Bérczi, A., Szekeres, T., Faulk, W. P., & Goldenberg, H. (1992) · International Journal of Cancer · doi:10.1002/ijc.2910520421 · Cited by 41
Weinberg, E. D. (1981) · Biological Trace Element Research · doi:10.1007/bf02789123 · Cited by 41
Lei, H., Hou, G., Liu, L., Pei, Z., Chen, Y., Lu, Y., Yang, N., Sun, S., & Cheng, L. (2024) · ACS Nano · doi:10.1021/acsnano.4c06199 · Cited by 41
Abraham, B. K., Justenhoven, C., Pesch, B., Harth, V., Weirich, G., Baisch, C., Rabstein, S., Ko, Y., Brüning, T., Fischer, H., et al. (2005) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-05-0013 · Cited by 40
Panaccio, M., Zalcberg, J. R., Thompson, C. H., Leyden, M. J., Sullivan, J. R., Lichtenstein, M., & McKenzie, I. F. C. (1987) · Immunology and Cell Biology · doi:10.1038/icb.1987.55 · Cited by 39
Extramammary Paget's cells: Further evidence of sweat gland derivation
Hamm, H., Feltkamp‐Vroom, T. M., & Czarnetzki, B. M. (1986) · Journal of the American Academy of Dermatology · doi:10.1016/s0190-9622(86)70302-2 · Cited by 40
Piacenti‐Silva, M., Zucchi, O. L. A. D., Ribeiro-Silva, A., & Poletti, M. E. (2009) · Spectrochimica Acta Part B Atomic Spectroscopy · doi:10.1016/j.sab.2009.05.026 · Cited by 38
Guan, P., & Wang, N. (2014) · Nutrition · doi:10.1016/j.nut.2013.12.016 · Cited by 38
Iron chelators as therapeutic iron depletion agents
Birch, N. W., Wang, X., & Chong, H. (2006) · Expert Opinion on Therapeutic Patents · doi:10.1517/13543776.16.11.1533 · Cited by 36
Transferrin receptor is inversely correlated with estrogen receptor in breast cancer
Tonik, S. E., Shindelman, J. E., & Sussman, H. H. (1986) · Breast Cancer Research and Treatment · doi:10.1007/bf01806791 · Cited by 36
Muraszko, K. M., Sung, C., Walbridge, S., Greenfield, L., Dedrick, R. L., Oldfield, E. H., & Youle, R. J. (1993) · PubMed · Cited by 36
Sensitivity of human glioma cells to cytotoxic heteroconjugates
Colombatti, M., Bisconti, M., Dell'Arciprete, L., Gerosa, M. A., & Tridente, G. (1988) · International Journal of Cancer · doi:10.1002/ijc.2910420322 · Cited by 36
Current Concepts in Iron Metabolism
Aisen, P. (1982) · Clinics in Haematology · doi:10.1016/s0308-2261(21)00336-2 · Cited by 36
Hofman, P. M., Hsi, B. ‐., Manié, S. N., Fénichel, P., Thyss, A., & Rossi, B. (1994) · Breast Cancer Research and Treatment · doi:10.1007/bf00665772 · Cited by 34
Costa, G. G. D., Gomig, T. H. B., Kaviski, R., Sousa, K. S., Kukolj, C., de Lima, R. S., Urban, C. D. A., Cavalli, I. J., & Ribeiro, E. M. S. F. (2015) · PubMed · Cited by 33
Trace Elements and Healthcare: A Bioinformatics Perspective
Zhang, Y. (2017) · Advances in experimental medicine and biology · doi:10.1007/978-981-10-5717-5_4 · Cited by 34
Zhang, Q., Wang, N., Ma, M., Luo, Y., & Chen, H. (2019) · Advanced Therapeutics · doi:10.1002/adtp.201800152 · Cited by 33
Ippoliti, R., Lendaro, E., D'Agostino, I., Fiani, M. L., Guidarini, D., Vestri, S., Benedetti, P. A., & Brunori, M. (1995) · The FASEB Journal · doi:10.1096/fasebj.9.12.7672515 · Cited by 33
Inhibition of transplasma membrane electron transport by transferrin-adriamycin conjugates
SUN, I. L., Sun, E. E., Crane, F. L., Morré, D. J., & Faulk, W. P. (1992) · Biochimica et Biophysica Acta (BBA) - Biomembranes · doi:10.1016/0005-2736(92)90165-i · Cited by 33
The role of the NDRG1 in the pathogenesis and treatment of breast cancer
Zhao, X., & Richardson, D. R. (2023) · Biochimica et Biophysica Acta (BBA) - Reviews on Cancer · doi:10.1016/j.bbcan.2023.188871 · Cited by 34
Cavanaugh, P. G. (2002) · Breast Cancer Research and Treatment · doi:10.1023/a:1014811915564 · Cited by 32
Calvo, F. M., Brower, M., & Carney, D. N. (1984) · PubMed · Cited by 32
Complexation of ytterbium to human transferrin and its uptake by K562 cells
Du, X., Zhang, T., Yuan, L., Zhao, Y., Li, R., Wang, K., Yan, S., Zhang, L., Sun, H., & Qian, Z. (2002) · European Journal of Biochemistry · doi:10.1046/j.1432-1033.2002.03326.x · Cited by 31
Enns, C. A., Rutledge, E. A., & Williams, A. M. (1996) · Biomembranes · doi:10.1016/s1874-5342(96)80012-2 · Cited by 33
IMMUNOBIOLOGY OF THE HUMAN TROPHOBLAST
JOHNSON, P. M. (1984) · Elsevier eBooks · doi:10.1016/b978-0-408-10865-2.50013-x · Cited by 31
Bile acid-based polyaminocarboxylate conjugates as targeted antitumor agents
Chong, H., Song, H. A., Ma, X., Lim, S., Sun, X. Y., & Mhaske, S. B. (2009) · Chemical Communications · doi:10.1039/b823000e · Cited by 30
Transferrin Binding by Peripheral Blood Mononuclear Cells in Human Lymphomas, Myelomas and Leukemias
Yeh, C. G., Taylor, C. G., & Faulk, W. P. (1984) · Vox Sanguinis · doi:10.1111/j.1423-0410.1984.tb00078.x · Cited by 30
Lack of a significant independent effect of race on survival in breast cancer
Dansey, R., Hessel, P. A., Browde, S., Lange, M., Derman, D. P., Nissenbaum, M., & Bezwoda, W. R. (1988) · Cancer · doi:10.1002/1097-0142(19880501)61:9 · Cited by 42
Transferrin receptor affinity and iron transport in the human placenta
Brown, P. J., Molloy, C., & Johnson, P. M. (1982) · Placenta · doi:10.1016/s0143-4004(82)80014-3 · Cited by 30
Kotsopoulos, J., Sukiennicki, G., Muszyńska, M., Gackowski, D., Kąklewski, K., Durda, K., Jaworska, K., Huzarski, T., Gronwald, J., Byrski, T., et al. (2012) · Cancer Causes & Control · doi:10.1007/s10552-012-9975-0 · Cited by 29
Voest, E. E., Neijt, J. P., KEUNEN, J. E. E., Dekker, A. W., van Asbeck, B. S., Nortier, J. W. R., Ros, F. E., & Marx, J. J. M. (1993) · Cancer Chemotherapy and Pharmacology · doi:10.1007/bf00686148 · Cited by 29
Bergamaschi, G., Cazzola, M., Dezza, L., Savino, E., Consonni, L., & Lappi, D. A. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb04218.x · Cited by 29
Fontana, F., Esser, A. K., Egbulefu, C., Karmakar, P. S., Su, X., Allen, J. S., Xu, Y., Davis, J. L., Gabay, A. J., Xiang, J., et al. (2023) · PLoS ONE · doi:10.1371/journal.pone.0293700 · Cited by 32
The core control system of intracellular iron homeostasis: A mathematical model
Chifman, J., Kniss, A., Neupane, P., Williams, I., Leung, B., Deng, Z., Mendes, P., Hower, V., Torti, F. M., Akman, S. A., et al. (2012) · Journal of Theoretical Biology · doi:10.1016/j.jtbi.2012.01.024 · Cited by 28
Gupta, J., Ahmed, A. T., Tayyib, N. A., Zabibah, R. S., Shomurodov, Q., Kadheim, M. N., Alsaikhan, F., Ramaiah, P., Chinnasamy, L., & Samarghandian, S. (2023) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2023.115337 · Cited by 28
Synthesis and Evaluation of Novel Polyaminocarboxylate-Based Antitumor Agents
Chong, H., Ma, X., Lee, H., Bui, P. M., Song, H. A., & Birch, N. W. (2008) · Journal of Medicinal Chemistry · doi:10.1021/jm701307j · Cited by 28
Bérczi, A., Ruthner, M., Szüts, V., Fritzer, M., Schweinzer, E., & Goldenberg, H. (1993) · European Journal of Biochemistry · doi:10.1111/j.1432-1033.1993.tb17778.x · Cited by 28
McIntyre, J. A., Hsi, B. ‐., Faulk, W. P., Klopper, A. I., & Thomson, R. (1981) · PubMed · Cited by 28
Anti-cancer activity of an acid-labile N-alkylisatin conjugate targeting the transferrin receptor
Chandran, V. I., Matesic, L., Locke, J. M., Skropeta, D., Ranson, M., & Vine, K. L. (2011) · Cancer Letters · doi:10.1016/j.canlet.2011.10.021 · Cited by 27
Effect of cerium lanthanide on Hela and MCF-7 cancer cell growth in the presence of transferring.
Palizban, A., Sadeghi‐Aliabadi, H., & Abdollahpour, F. (2010) · PubMed Central · Cited by 27
Ali, S. A., João, H. C., Hammerschmid, F., Eder, J., & Steinkasserer, A. (1999) · Journal of Biological Chemistry · doi:10.1074/jbc.274.34.24066 · Cited by 26
A Phase II Trial of Deferoxamine in Patients with Hormone-Refractory Metastatic Prostate Cancer
Dreicer, R., Kemp, J. D., Stegink, L. D., Cardillo, T. M., Davis, C. S., Forest, P. K., & See, W. A. (1997) · Cancer Investigation · doi:10.3109/07357909709039731 · Cited by 25
Transferrin receptors in injured brain
Orita, T., Akimura, T., Nishizaki, T., Kamiryo, T., Ikeyama, Y., Aoki, H., & Ito, H. (1990) · Acta Neuropathologica · doi:10.1007/bf00294248 · Cited by 25
Lesley, J., & Schulte, R. J. (1984) · Molecular and Cellular Biology · doi:10.1128/mcb.4.9.1675 · Cited by 25
Identification SYT13 as a novel biomarker in lung adenocarcinoma
Zhang, L., Fan, B., Zheng, Y., Lou, Y., Cui, Y., Wang, K., Zhang, T., & Tan, X. (2019) · Journal of Cellular Biochemistry · doi:10.1002/jcb.29224 · Cited by 24
Identification and characterization of the chicken transferrin receptor
Schmidt, J. A., Marshall, J., & Hayman, M. J. (1985) · Biochemical Journal · doi:10.1042/bj2320735 · Cited by 24
Lenarduzzi, M., Hui, A. B., Yue, S., Ito, E., Shi, W., Williams, J. P., Bruce, J., Sakemura-Nakatsugawa, N., Xu, W., Schimmer, A. D., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0074075 · Cited by 23
Infusion rates and drug distribution in brain tumor models in rats
Khan, A., Jallo, G. I., Liu, Y. J., Carson, B. S., & Guarnieri, M. (2005) · Journal of neurosurgery · doi:10.3171/ped.2005.102.1.0053 · Cited by 23
Transferrin Receptor Activity as a Marker in Transitional Cell Carcinoma of the Bladder
BAşAR, I., Ayhan, A., Bircan, K., Ergen, A., & TAşAR, ̧. (1991) · British Journal of Urology · doi:10.1111/j.1464-410x.1991.tb15101.x · Cited by 23
Influence of iron on infection
Ward, C. (1986) · The American Journal of Surgery · doi:10.1016/0002-9610(86)90090-5 · Cited by 23
Transferrin receptors in cultured breast cancer cells
Vandewalle, B., Granier, A., Peyrat, J. P., Bonneterre, J. M., & Lefèbvre, J. L. (1985) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf00402505 · Cited by 22
Diferric transferrin reduction by K562 cells. A critical study
Bérczi, A., SIZENSKY, J. A., Crane, F. L., & Faulk, W. P. (1991) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/0304-4165(91)90231-5 · Cited by 22
The Immunoregulatory Nature of Iron. II. Lymphocyte Surface Marker Expression
Bryan, C. F., Leech, S. H., & Bozelka, B. E. (1986) · Journal of Leukocyte Biology · doi:10.1002/jlb.40.5.589 · Cited by 22
Shirakihara, T., Yamaguchi, H., Kondo, T., Yashiro, M., & Sakai, R. (2022) · Oncogene · doi:10.1038/s41388-022-02270-5 · Cited by 22
Transferrin receptor and ferritin levels during murine mammary gland development
Schulman, H. M., Ponka, P., Wilczynska, A., Gauthier, Y., & Shyamala, G. (1989) · Biochimica et Biophysica Acta (BBA) - Molecular Cell Research · doi:10.1016/0167-4889(89)90176-6 · Cited by 21
Modulation of the transferrin receptor during DMSO-induced differentiation in HL-60 cells
Enns, C. A., Mulkins, M. A., Sussman, H. H., & Root, B. J. (1988) · Experimental Cell Research · doi:10.1016/0014-4827(88)90144-9 · Cited by 21
Transferrin receptor bearing cells in the peripheral blood of patients with rheumatoid arthritis.
Salmon, M., BACON, P. A., Symmons, D. P. M., & Blann, A. D. (1985) · PubMed Central · Cited by 21
Murine monoclonal antibodies in breast cancer: An overview
Tjandra, J. J., & McKenzie, I. F. C. (1988) · British journal of surgery · doi:10.1002/bjs.1800751107 · Cited by 20
Transferrin receptor expression on AML blasts is related to their proliferative potential
Kozlowski, R., Reilly, I. A. G., Sowter, D., Robins, R. A., & Russell, N. H. (1988) · British Journal of Haematology · doi:10.1111/j.1365-2141.1988.tb07633.x · Cited by 18
Continuous growth of human tumor cell lines in serum-free media
Zirvi, K. A., Chee, D. O., & Hill, G. J. (1986) · In Vitro Cellular & Developmental Biology - Plant · doi:10.1007/bf02623524 · Cited by 18
Transferrin receptor expression by stimulated cells in mixed lymphocyte culture.
Salmon, M., BACON, P. A., Symmons, D. P. M., & WALTON, K. W. (1985) · PubMed Central · Cited by 18
Recent Advances in Cancer Research: Drug Targeting Without the Use of Monoclonal Antibodies
Faulk, W. P., HARATS, H., McIntyre, J. A., Bérczi, A., SUN, I. L., & Crane, F. L. (1989) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1989.tb01021.x · Cited by 18
Transferrin and transferrin receptor in human hypophysis and pituitary adenomas.
Tampanaru-Sarmesiu, A., Ştefăneanu, L., Thapar, K., Kontogeorgos, G., Sumi, T., & Kovács, K. (1998) · Europe PMC (PubMed Central) · Cited by 17
Total parenteral nutrition and cancer clinical trials
Klein, S., Simes, R. J., & Blackburn, G. L. (1986) · Cancer · doi:10.1002/1097-0142(19860915)58:6 · Cited by 243
Barabás, K., SIZENSKY, J. A., & Faulk, W. P. (1991) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1991.tb01078.x · Cited by 17
Transformation-induced changes in transferrin and iron metabolism in myogenic cells.
Sorokin, L. M., Morgan, E. H., & Yeoh, G. C. (1989) · PubMed · Cited by 16
Lipophilic aroylhydrazone chelator HNTMB and its multiple effects on ovarian cancer cells
Kim, K., Lange, T. S., Singh, R. K., & Brard, L. (2010) · BMC Cancer · doi:10.1186/1471-2407-10-72 · Cited by 16
Pharmaceutical formulation affects titanocene transferrin interactions
Buettner, K. M., Snoeberger, R. C., Batista, V. S., & Valentine, A. M. (2011) · Dalton Transactions · doi:10.1039/c1dt10805k · Cited by 15
Yeh, C. G., Hsi, B., & Faulk, W. P. (1983) · Placenta · doi:10.1016/s0143-4004(83)80039-3 · Cited by 15
Role of Fe, Transferrin and Transferrin Receptor in Anti-Tumor Effect of Vitamin C
Qiu, J., Wu, R., Long, Y., Peng, L., Yang, T., Zhang, B., Shi, X., Liu, J., & Zhang, X. (2022) · Cancers · doi:10.3390/cancers14184507 · Cited by 14
Immunotherapy for Recurrent Spontaneous Abortion and its Analogies to Treatment for Cancer
Coulam, C. B., Faulk, W. P., & McIntyre, J. A. (1991) · American Journal of Reproductive Immunology · doi:10.1111/j.1600-0897.1991.tb01077.x · Cited by 14
Biological meaning of stage and grade in human breast cancer: Review and hypothesis
Sharkey, F. E. (1982) · Breast Cancer Research and Treatment · doi:10.1007/bf01805872 · Cited by 14
Synthesis of 1,3,5-cis,cis-Triaminocyclohexane N-Pyridyl Derivatives as Potential Antitumor Agents
Chong, H., Torti, F. M., Torti, S. V., & Brechbiel, M. W. (2002) · The Journal of Organic Chemistry · doi:10.1021/jo0204911 · Cited by 14
Yeh, C. G., Faulk, W. P., & Taylor, C. G. (1985) · Protides of the biological fluids · doi:10.1016/b978-0-08-031739-7.50111-7 · Cited by 14
Szulc, A., & Woźniak, M. (2025) · International Journal of Molecular Sciences · doi:10.3390/ijms26209902 · Cited by 17
Repositioning of zoledronic acid for breast cancer using transferrin-conjugated liposome
Choi, M., Shin, D. H., & Kim, J. (2013) · Journal of Pharmaceutical Investigation · doi:10.1007/s40005-013-0091-2 · Cited by 13
Graff, R. E., Cho, E., Lindström, S., Kraft, P. L., Willett, W. C., & Eliassen, A. H. (2014) · Cancer Epidemiology Biomarkers & Prevention · doi:10.1158/1055-9965.epi-13-0907 · Cited by 13
Piacenti‐Silva, M., Silva, D. M., Conceição, A. L. C., Ribeiro‐Silva, A., & Poletti, M. E. (2013) · X-Ray Spectrometry · doi:10.1002/xrs.2470 · Cited by 13
Alonso-García, F. J., Blanco‐González, E., & Montes‐Bayón, M. (2018) · Talanta · doi:10.1016/j.talanta.2018.10.020 · Cited by 13
Increase of transferrin receptors in hepatocytes during rat liver regeneration
Hirose-Kumagai, A., Sakai, H., & Akamatsu, N. (1984) · International Journal of Biochemistry · doi:10.1016/0020-711x(84)90028-4 · Cited by 13
Therapy-induced senescence in breast cancer: an overview
Narayanan, C. S., & Lindsay, A. J. (2024) · Exploration of Targeted Anti-tumor Therapy · doi:10.37349/etat.2024.00254 · Cited by 12
Shpilt, Z., & Tshuva, E. Y. (2021) · Journal of Inorganic Biochemistry · doi:10.1016/j.jinorgbio.2022.111817 · Cited by 12
Lazarus, A. H., & Baines, M. G. (1985) · Journal of Immunological Methods · doi:10.1016/0022-1759(85)90101-2 · Cited by 12
Metadata
- Authors
- Page Faulk, W., Hsi, B.-L., & Stevens, P. J.
- Affiliations
- Queen Victoria Hospital (GB)
- Venue
- The Lancet
- Publisher
- Elsevier BV
- Published
- 1980-08
- Volume
- 316
- Issue
- 8191
- Pages
- 390-392
- ISSN
- 0099-5355 (ISSN-L)
- 0140-6736
- OpenAlex
- W2079229575
- Cited by
- 280
- References
- 18
- Citations by year
- 2026: 2 · 2025: 8 · 2024: 2 · 2023: 6 · 2022: 3 · 2021: 3 · 2020: 3 · 2019: 8 · 2018: 5 · 2017: 8 · 2015: 3 · 2014: 8 · 2013: 6 · 2012: 8
- FWCI
- 8.97
- Type
- journal article
- Language
- en
- Open access
- closed
- Locations
- The Lancet (publishedVersion)
- PubMed (publishedVersion)
- Topics
- Health Sciences › Medicine › Hematology › Iron Metabolism and Disorders
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Breast Cancer Treatment Studies
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Cancer Research › Ferroptosis and cancer prognosis
- Keywords
- transferrin, transferrin receptor, breast cancer, apotransferrin, oncofetal protein, tumor cell membrane, fibroadenoma, benign breast disease, breast cancer treatment
- MeSH terms
- Breast, Breast Neoplasms, Cell Membrane, Female, Fetal Proteins, Fluorescent Antibody Technique, Humans, Receptors, Cell Surface, Transferrin
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review